Aspira Pathlab & Diagnostics Stock Performance
as on July 13, 2026 at 9:31 pm IST
Day's High
₹94.90₹101.857.32%
Upside

52 Week's Low
52 Week's High
₹49.00₹135.88
48.37%
Downside
43.18%
Upside

Aspira Pathlab & Diagnostics share price movements today
- Previous Close
- ₹99.85
- Open
- ₹98.85
- Volume
- 124.00
- Upper Circuit
- ₹104.80
- Lower Circuit
- ₹94.90
- Day's Low - High
- ₹94.90 - ₹101.85
- 52 Week Low - High
- ₹49.00 - ₹135.88
Aspira Pathlab & Diagnostics Historical Returns
- 1 Month Return
- -19.3 %
- 3 Month Return
- + 60.2 %
- 1 Year Return
- + 80.76 %
- 3 Year Return
- + 239.53 %
- 5 Year Return
- + 175.07 %
Aspira Pathlab & Diagnostics Fundamentals
as on July 13, 2026 at 4:01 pm IST
Market Cap
₹102.78 Cr
Return on Equity (ROE)
16.88
PE Ratio (TTM)
1997
Return on capital employed (ROCE)
11.71
Industry PE ratio
55.35
Beta (LTM)
0.07
P/B Ratio
12.04
Dividend Yield
0PEG Ratio
-1018.88
Quarterly Earnings Growth YOY
740
EPS (TTM)
1.97
Book Value
7.03
Aspira Pathlab & Diagnostics Stock Valuation
as on July 13, 2026 at 4:01 pm IST
Aspira Pathlab & Diagnostics in the last 5 years
Lowest (-387.44x)
May 10, 2023
Industry (55.35x)
July 13, 2026
Today (1898.00x)
July 13, 2026
Highest (2665.80x)
May 29, 2026
Today’s Price to Earnings Ratio: 1898.00x
Aspira Pathlab & Diagnostics Technical Analysis
Track how Aspira Pathlab & Diagnostics technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0 | Bullish |
CCI (20) | -66.67 | Neutral |
RSI (14) | 25.64 | Bullish |
Momentum (10) | 0 | Neutral |
ADI (14) | 98.17 | Neutral |
Ultimate Oscillator (7,14,28) | 0 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 94.9 | Neutral |
EMA (20) | 94.9 | Neutral |
VWMA (20) | 94.9 | Neutral |
SMA (50) | 94.9 | Neutral |
EMA (50) | 94.9 | Neutral |
SMA (200) | 94.9 | Neutral |
EMA (200) | 95.07 | |
KAMA (200) | 94.9 | Neutral |
DEMA (200) | 94.39 | Bullish |
Aspira Pathlab & Diagnostics Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aspira Pathlab & Diagnostics with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 102.78 | 37.88% | 0.58 | 2 | 22 | |
| NA | 520.15 | 288.18% | 0.00 | NA | NA | |
| BUY | 2,369.29 | 202.54% | 0.00 | 54 | 397 | |
| BUY | 28,377.72 | -0.35% | 0.54 | 509 | 2,762 | |
| NA | 60.18 | 2.49% | 0.63 | 5 | 167 |
Aspira Pathlab & Diagnostics Stock’s Investor Sentiment and Interest
Search interest for Aspira Pathlab & Diagnostics Ltd Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Aspira Pathlab & Diagnostics Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Aspira Pathlab & Diagnostics Ltd Annual Profit & Loss
Figures in Rupees Crores
Aspira Pathlab & Diagnostics Ltd Cash Flow
Figures in Rupees Crores
Aspira Pathlab & Diagnostics Corporate Actions
View detailed summary of the earnings and dividend history of Aspira Pathlab & Diagnostics.
Aspira Pathlab & Diagnostics Ltd Earnings Results
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 740% since last year same period to ₹0.42Cr in the Q1 2025-2026. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated -38.24% fall in its net profits since last 3-months.
Read More about Earnings Results
Insights on Aspira Pathlab & Diagnostics Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year

In the last 1 year, Aspira Pathlab has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
POSITIVE IMPACTBest in 3 Years

In the last 3 years, Aspira Pathlab has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 18.39% of holdings in Mar 2026 quarter
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 81.61% of holdings in Mar 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 7 days, Aspira Pathlab stock has moved down by -18.5%
About Aspira Pathlab & Diagnostics Ltd
Revenue: ₹5.25Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.42Cr as on June 2025 (Q1 FY26)
Chairperson Name: Haseeb Drabu
| Organisation | Aspira Pathlab & Diagnostics Ltd |
| Headquarters | Mumbai |
| Industry | Healthcare |
| CEO | Haseeb Drabu |
| E-voting on shares | Click here to vote |
FAQs
What is Aspira Pathlab & Diagnostics share price today?
Aspira Pathlab & Diagnostics share price today stands at ₹94.9 as on at the close of the market. Aspira Pathlab & Diagnostics share today touched a day high of ₹101.85 and a low of ₹94.9.
What is the 52 week high and 52 week low range for Aspira Pathlab & Diagnostics share?
Aspira Pathlab & Diagnostics touched a 52 week high of ₹135.88 and a 52 week low of ₹49. Aspira Pathlab & Diagnostics share price today i.e. is closed at ₹94.9, which is -30.16% down from its 52 week high and 93.67% up from its 52 week low.
What is Aspira Pathlab & Diagnostics's market capitalisation today?
Aspira Pathlab & Diagnostics market capitalisation is ₹97.68 Cr as on .
How to buy Aspira Pathlab & Diagnostics shares?
To buy Aspira Pathlab & Diagnostics shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 540788 or Aspira Pathlab & Diagnostics Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Aspira Pathlab & Diagnostics shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Aspira Pathlab & Diagnostics trading volume today?
Aspira Pathlab & Diagnostics trading volume is 124.00 as on . This means that 124.00 shares of Aspira Pathlab & Diagnostics were bought and sold on the stock market during today's trading session.